Using a gene targeting approach, Nanda et al (2006) have shown that endosialin is dispensable for normal development and subcutaneous tumour growth, but can modulate invasiveness and metastatic progression in an orthotopic xenograft model of colorectal cancer. Here, CD248 is linked to neoplasm.